{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:14:44Z","timestamp":1790874884557,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-025-03282-x","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T06:40:56Z","timestamp":1750315256000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Innovating care for people with sarcoidosis using a machine learning-driven approach"],"prefix":"10.1186","volume":"26","author":[{"given":"Vivienne","family":"Kahlmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Dunweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heleen","family":"Kicken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Jelicic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna M.","family":"Hendriks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Goossens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies S.","family":"Wijsenbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"issue":"2","key":"3282_CR1","first-page":"127","volume":"21","author":"J De Vries","year":"2004","unstructured":"De Vries J, Rothkrantz-Kos S, van Dieijen-Visser MP, Drent M. The relationship between fatigue and clinical parameters in pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2004;21(2):127\u201336.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"4","key":"3282_CR2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1159\/000092670","volume":"74","author":"HJ Michielsen","year":"2007","unstructured":"Michielsen HJ, Peros-Golubicic T, Drent M, De Vries J. Relationship between symptoms and quality of life in a sarcoidosis population. Respiration. 2007;74(4):401\u20135.","journal-title":"Respiration"},{"issue":"5","key":"3282_CR3","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00408-018-0144-4","volume":"196","author":"CC Moor","year":"2018","unstructured":"Moor CC, van Manen MJG, van Hagen PM, Miedema JR, van den Toorn LM, Gur-Demirel Y, et al. Needs, perceptions and education in sarcoidosis: a live interactive survey of patients and partners. Lung. 2018;196(5):569\u201375.","journal-title":"Lung"},{"issue":"5","key":"3282_CR4","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1159\/000501657","volume":"98","author":"M Voortman","year":"2019","unstructured":"Voortman M, Hendriks CMR, Lodder P, Drent M, De Vries J. Quality of life of couples living with sarcoidosis. Respiration. 2019;98(5):373\u201382.","journal-title":"Respiration"},{"key":"3282_CR5","doi-asserted-by":"publisher","first-page":"107174","DOI":"10.1016\/j.rmed.2023.107174","volume":"210","author":"MA Judson","year":"2023","unstructured":"Judson MA, Spagnolo P, Stanfel R, Farrow G, Tanase AM, Perna F, Baughman RP. Living with sarcoidosis: Virtual roundtable dialogue with patients and healthcare professionals. Respir Med. 2023;210:107174.","journal-title":"Respir Med"},{"issue":"4","key":"3282_CR6","doi-asserted-by":"publisher","first-page":"00141","DOI":"10.1183\/23120541.00141-2018","volume":"4","author":"RP Baughman","year":"2018","unstructured":"Baughman RP, Barriuso R, Beyer K, Boyd J, Hochreiter J, Knoet C, et al. Sarcoidosis: patient treatment priorities. ERJ Open Res. 2018;4(4):00141.","journal-title":"ERJ Open Res."},{"issue":"2","key":"3282_CR7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00408-019-00206-7","volume":"197","author":"M Voortman","year":"2019","unstructured":"Voortman M, Hendriks CMR, Elfferich MDP, Bonella F, Moller J, De Vries J, et al. The burden of sarcoidosis symptoms from a patient perspective. Lung. 2019;197(2):155\u201361.","journal-title":"Lung"},{"issue":"2","key":"3282_CR8","first-page":"19","volume":"17","author":"J Jung","year":"2023","unstructured":"Jung J, Kim KH, Peters T, Snelders D, Kleinsmann M. Advancing design approaches through data-driven techniques: patient community journey mapping using online stories and machine learning. Int J Des. 2023;17(2):19\u201344.","journal-title":"Int J Des"},{"key":"3282_CR9","unstructured":"Barbieri F, Espinosa AL, Camacho-Collados J. XLM-T: Multilingual Language Models in Twitter for Sentiment Analysis and Beyond. In Proceedings of the Thirteenth Language Resources and Evaluation Conference. Marseille: European Language Resources Association; 2022;258\u201366.\u00a0"},{"issue":"8","key":"3282_CR10","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1164\/rccm.201906-1250OC","volume":"201","author":"LJ Harper","year":"2020","unstructured":"Harper LJ, Gerke AK, Wang XF, Ribeiro Neto ML, Baughman RP, Beyer K, et al. Income and other contributors to poor outcomes in U.S. Patients with sarcoidosis. Am J Respir Crit Care Med. 2020;201(8):955\u201364.","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"3282_CR11","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1016\/j.rmed.2008.05.001","volume":"102","author":"BS Gvozdenovic","year":"2008","unstructured":"Gvozdenovic BS, Mihailovic-Vucinic V, Ilic-Dudvarski A, Zugic V, Judson MA. Differences in symptom severity and health status impairment between patients with pulmonary and pulmonary plus extrapulmonary sarcoidosis. Respir Med. 2008;102(11):1636\u201342.","journal-title":"Respir Med"},{"issue":"5","key":"3282_CR12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1159\/000529890","volume":"102","author":"K Buschulte","year":"2023","unstructured":"Buschulte K, Hoger P, Ganter C, Wijsenbeek M, Kahn N, Kriegsmann K, et al. How informed are German patients with pulmonary sarcoidosis about their disease? Respiration. 2023;102(5):361\u20139.","journal-title":"Respiration"},{"key":"3282_CR13","doi-asserted-by":"publisher","first-page":"1217146","DOI":"10.3389\/fmed.2023.1217146","volume":"10","author":"K Buschulte","year":"2023","unstructured":"Buschulte K, Hoger P, Ganter C, Wijsenbeek M, Kahn N, Kriegsmann K, et al. Is the internet a sufficient source of information on sarcoidosis? Front Med (Lausanne). 2023;10:1217146.","journal-title":"Front Med (Lausanne)"},{"key":"3282_CR14","doi-asserted-by":"publisher","first-page":"2004079","DOI":"10.1183\/13993003.04079-2020","volume":"58","author":"RP Baughman","year":"2021","unstructured":"Baughman RP, Valeyre D, Korsten P, Mathioudakis AG, Wuyts WA, Wells A, et al. ERS clinical practice guidelines on treatment of sarcoidosis. Eur Respir J. 2021;58:2004079.","journal-title":"Eur Respir J"},{"key":"3282_CR15","doi-asserted-by":"publisher","unstructured":"Kahlmann V, Moor CC, van Helmondt SJ, Mostard RLM, van der Lee ML, Grutters JC, et al. Online mindfulness-based cognitive therapy for fatigue in patients with sarcoidosis (TIRED): a randomised controlled trial. Lancet Respir Med.\u00a02023;11(3):265\u201372. https:\/\/doi.org\/10.1016\/S2213-2600(22)00387-3.","DOI":"10.1016\/S2213-2600(22)00387-3"},{"key":"3282_CR16","doi-asserted-by":"publisher","first-page":"101062","DOI":"10.1016\/j.conctc.2023.101062","volume":"32","author":"J Chandler","year":"2023","unstructured":"Chandler J, Christon LM, Benfield K, Pairet S, Hoffman M, Treiber F, et al. Design and rationale of a pilot randomized clinical trial investigating the use of a mHealth app for sarcoidosis-associated fatigue. Contemp Clin Trials Commun. 2023;32:101062.","journal-title":"Contemp Clin Trials Commun"},{"issue":"1","key":"3282_CR17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S2213-2600(22)00228-4","volume":"11","author":"MS Wijsenbeek","year":"2023","unstructured":"Wijsenbeek MS, Moor CC, Johannson KA, Jackson PD, Khor YH, Kondoh Y, et al. Home monitoring in interstitial lung diseases. Lancet Respir Med. 2023;11(1):97\u2013110.","journal-title":"Lancet Respir Med"},{"key":"3282_CR18","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1016\/j.rmed.2017.10.022","volume":"138S","author":"CE Broos","year":"2018","unstructured":"Broos CE, Poell LHC, Looman CWN, In \u2018t Veen JCCM, Grootenboers M, Heller R, et al. No evidence found for an association between prednisone dose and FVC change in newly-treated pulmonary sarcoidosis. Respir Med. 2018;138S:S31\u20137.","journal-title":"Respir Med"},{"issue":"3","key":"3282_CR19","doi-asserted-by":"publisher","first-page":"2300198","DOI":"10.1183\/13993003.00198-2023","volume":"62","author":"S Dhooria","year":"2023","unstructured":"Dhooria S, Sehgal IS, Agarwal R, Muthu V, Prasad KT, Dogra P, et al. High-dose (40 mg) versus low-dose (20 mg) prednisolone for treating sarcoidosis: a randomised trial (SARCORT trial). Eur Respir J. 2023;62(3):2300198.","journal-title":"Eur Respir J"},{"issue":"2","key":"3282_CR20","doi-asserted-by":"publisher","first-page":"e002167","DOI":"10.1136\/rmdopen-2021-002167","volume":"8","author":"JM Gwinnutt","year":"2022","unstructured":"Gwinnutt JM, Wieczorek M, Rodriguez-Carrio J, Balanescu A, Bischoff-Ferrari HA, Boonen A, et al. Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs. RMD Open. 2022;8(2):e002167.","journal-title":"RMD Open"},{"issue":"3","key":"3282_CR21","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1136\/ard.62.3.208","volume":"62","author":"L Skoldstam","year":"2003","unstructured":"Skoldstam L, Hagfors L, Johansson G. An experimental study of a Mediterranean diet intervention for patients with rheumatoid arthritis. Ann Rheum Dis. 2003;62(3):208\u201314.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"3282_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.5539\/gjhs.v8n7p18","volume":"8","author":"E Rajaei","year":"2015","unstructured":"Rajaei E, Mowla K, Ghorbani A, Bahadoram S, Bahadoram M, Dargahi-Malamir M. The effect of omega-3 fatty acids in patients with active rheumatoid arthritis receiving DMARDs therapy: double-blind randomized controlled trial. Glob J Health Sci. 2015;8(7):18\u201325.","journal-title":"Glob J Health Sci"},{"key":"3282_CR23","doi-asserted-by":"crossref","unstructured":"Arkema EV, Eklund A, Grunewald J, Bruze G. Work ability before and after sarcoidosis diagnosis in Sweden. Respir Med. 2018;144S:S7\u201312.","DOI":"10.1016\/j.rmed.2018.09.016"},{"issue":"4","key":"3282_CR24","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00408-019-00234-3","volume":"197","author":"CMR Hendriks","year":"2019","unstructured":"Hendriks CMR, Saketkoo LA, Elfferich MDP, De Vries J, Wijnen P, Drent M. Sarcoidosis and work participation: the need to develop a disease-specific core set for assessment of work ability. Lung. 2019;197(4):407\u201313.","journal-title":"Lung"},{"issue":"11","key":"3282_CR25","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/S2213-2600(24)00297-2","volume":"12","author":"M Drent","year":"2024","unstructured":"Drent M, Russell AM, Saketkoo LA, Spagnolo P, Veltkamp M, Wells AU. Representatives of the sarcoidosis c. Breaking barriers: holistic assessment of ability to work in patients with sarcoidosis. Lancet Respir Med. 2024;12(11):848\u201351.","journal-title":"Lancet Respir Med"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03282-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-025-03282-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03282-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T06:40:58Z","timestamp":1750315258000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-025-03282-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3282"],"URL":"https:\/\/doi.org\/10.1186\/s12931-025-03282-x","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]},"assertion":[{"value":"3 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the Human Research Ethics Committee of the Delft\u00a0University of Technology. As this was a retrospective study with anonymized web-based data no informed consent of the patients was required. Consent for the use of data was obtained from the platform owner.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"218"}}